Resistell among 10 promising European medtech startups to watch in 2020

Despite the fact that the spread of resistant bacteria is seen as one of the biggest global threats, pharmaceutical companies are pulling out of research into new antibiotics.

For the first time Resistell with its Rapid AST made it to TOP100 this year! We are super proud and have big ambitions to climb up the list! Stay tuned!

Join us in Zurich at the Annual Meeting of Swiss Society for Microbiology and learn more about our rapid AST solution. We invite you to our booth number 24. See you soon!

In the immensity of the cosmos, could life develop on another planet than Earth? Nano-motion device invented be Sandor Kasas and Giovanni Dietler from EPFL Lausanne...

Thank you for giving us the opportunity to take part in the Pitch Night Boston 2019: The Future of HealthTech and to present our rapid AST.

Join Resistell at OBERON to see our Rapid AST solution at Pitch Night 2019, where 10 of Switzerland’s most promising young HealthTech startups will pitch their ideas alongside their counterparts from North America, including some of the Boston area’s favorite early Life Sciences startups.

We would like to thank the colleagues from the Uppsala Antibiotic Centre for the invitation to an excellent Symposium on Rapid ASTs. We are impressed by the quality of the event, participants and the discussions and honoured to be an invited speaker.